Literature DB >> 15024178

Immune reconstitution and viral stimulation are required to restore HIV-specific CD8 T cell responses following advanced infection.

Jane Gamberg1, Lisa Barrett, Ian Bowmer, Constance Howley, Michael Grant.   

Abstract

The extent to which highly active antiretroviral therapy (HAART) restores human immunodeficiency virus (HIV)-specific immunity in advanced infection is unknown. Therefore, we studied how effective therapy affected HIV-specific CD8(+) T cell responses in 4 individuals who had progressed to advanced infection. CD8(+) T cell responses were assessed by cytotoxicity and interferon-gamma (IFN-gamma) production. Proliferative CD4(+) T cell responses against HIV, Candida and mitogen were measured by (3)H-thymidine incorporation. Substantial immune reconstitution indicated by increased CD4(+) and CD8(+) T cell numbers followed suppression of viral replication. This was associated with emergence of HIV-specific cytotoxic T lymphocytes (CTL), but only concurrent with detectable viral replication. Emergent anti-HIV CTL were similar to those at earlier stages of infection in terms of their specificity, function, and CD28 phenotype. However, they were very short-lived in the absence of detectable HIV replication. Antigen-specific CD4(+) T cell responses remained severely compromised. Thus, effective antiretroviral therapy restores the capacity for HIV-specific CTL responses after advanced infection. However, the transient nature of these responses suggests failure to generate stable long-lived memory cells in the absence of HIV-specific helper T cell responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024178     DOI: 10.1023/B:JOCI.0000019776.38147.e6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.542


  35 in total

1.  Functional and genetic integrity of the CD8 T-cell repertoire in advanced HIV infection.

Authors:  J C Gamberg; M I Bowmer; J C Trahey; C M Campbell; I Pardoe; M D Grant
Journal:  AIDS       Date:  1999-10-22       Impact factor: 4.177

2.  Skewed maturation of memory HIV-specific CD8 T lymphocytes.

Authors:  P Champagne; G S Ogg; A S King; C Knabenhans; K Ellefsen; M Nobile; V Appay; G P Rizzardi; S Fleury; M Lipp; R Förster; S Rowland-Jones; R P Sékaly; A J McMichael; G Pantaleo
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

3.  HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.

Authors:  R P Johnson; A Trocha; L Yang; G P Mazzara; D L Panicali; T M Buchanan; B D Walker
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

4.  HIV-specific cytotoxic T lymphocyte precursors exist in a CD28-CD8+ T cell subset and increase with loss of CD4 T cells.

Authors:  D E Lewis; L Yang; W Luo; X Wang; J R Rodgers
Journal:  AIDS       Date:  1999-06-18       Impact factor: 4.177

5.  Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors.

Authors:  S Feldman; D Stein; S Amrute; T Denny; Z Garcia; P Kloser; Y Sun; N Megjugorac; P Fitzgerald-Bocarsly
Journal:  Clin Immunol       Date:  2001-11       Impact factor: 3.969

6.  Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.

Authors:  L Mollet; T S Li; A Samri; C Tournay; R Tubiana; V Calvez; P Debré; C Katlama; B Autran
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

7.  Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease.

Authors:  T S Li; R Tubiana; C Katlama; V Calvez; H Ait Mohand; B Autran
Journal:  Lancet       Date:  1998-06-06       Impact factor: 79.321

8.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

9.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Authors:  Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Barry Bredt; Elilta Hagos; Harry Lampiris; Steven G Deeks
Journal:  J Infect Dis       Date:  2003-04-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.